UNSPSC 51101925: Chininum muriaticum

This classification denotes an antimalarial agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 711S8Y0T33. European Medicines Agency schedules Quinine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15093MIG. Quinine hydrochloride generally arises in the molecular formula C20H24N2O2.XCLH. The term 'quinine hydrochloride' is a United States Homeopathic Pharmacopoeia Name designation. SMILES: Cl.OC(C1N2CCC(C1)(CC2)C=C)c1c2c(ncc1)ccc(OC)c2.

UNSPSC 51101925 Chininum muriaticum, a Commodity code, shows minimal alignment with recent state and local procurement activity. The code nominally refers to chininum muriaticum (quinine hydrochloride), but the recent solicitations tagged under this code do not reflect purchases of that specific pharmaceutical ingredient. Instead, the opportunities posted involve broader pharmaceutical procurement — antibiotic tablets, naloxone, and drug deactivation systems — that fall outside the narrow scope of the code's name. State and local buyers posting under this code include the Illinois Department of Public Health and Seminole County, Florida, representing state health departments and county health authorities.

Recent activity shows no open solicitations under this code. The Illinois Department of Public Health completed an award on August 28, 2026 to Chartwell Rx LLC for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse cooperative purchasing vehicle, with a total contract value of $2,999,999.11 over the three-year term including renewals (IFB 26-482DPH-PREPD-B-53392). Seminole County, Florida issued an IFB on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, though the bid deadline listed (July 26, 2023) appears to be a historical record date. The code shows activity in Florida and Illinois but limited recent open solicitation volume. Firms evaluating this code should verify actual commodity alignment during opportunity review, as the code classification appears inconsistently applied relative to the pharmaceutical products being purchased.